DIRECT DETECT
DEAD

Serial Number

79303298

Owner

Insite Molecular Biosciences Pty Ltd

Filing Date

Dec 9, 2020

Add to watchlist:

No watchlists yet
View on USPTO

DIRECT DETECT Trademark

Serial Number: 79303298

DIRECT DETECT is a trademark filed by Insite Molecular Biosciences Pty Ltd on December 9, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Insite Molecular Biosciences Pty Ltd

5/26-34 Dunning Avenue

Entity Type: 99

Trademark Details

Filing Date

December 9, 2020

Registration Date

Not Registered

Goods & Services

Apparatus for the detection of micro-organisms in foods; food analysis apparatus; sensors for trace analysis in the food industry; scientific apparatus for testing samples of water

Clinical diagnostics for medical or veterinary use; chemical reagents for identification of microorganisms (medical or veterinary use); chemical reagents for medical or veterinary purposes; chemical reagents for use in diagnosis (medical or veterinary use); chemical reagents for use in medicine; chemical test reagents (medical); chemical test reagents (veterinary); diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; diagnostic reagents for in-vitro use (medical); diagnostic reagents for medical use; diagnostic reagents for medical use for sale in kit form; reagents for laboratory purposes (for medical purposes); reagents for microbiological analysis (for medical purposes); reagents for microbiological analysis (for veterinary purposes); reagents for protein folding (for medical purposes); reagents for protein folding (for veterinary purposes); reagents for use in analysis (for medical purposes); reagents for use in analysis (for veterinary purposes); reagents for use in analytical tests (for medical purposes); reagents for use in analytical tests (for veterinary purposes); reagents for use in diagnostic tests (for medical purposes); reagents for use in diagnostic tests (for veterinary purposes); reagents for use in medical diagnosis; test reagents for medical diagnosis; test reagents for medical use; veterinary diagnostic reagents

Chemical diagnostic reagents for industrial use; chemical diagnostic reagents for scientific use; chemical reagents for use in analytical tests, other than for medical or veterinary use; chemical reagents for use in science, other than for medical or veterinary use; chemical test reagents (other than for medical or veterinary use); diagnostic reagents, other than for medical laboratory use; reagents for industrial purposes; reagents for testing water; reagents for use in environmental analysis; reagents for use in environmental testing

Medical diagnostic services (testing and analysis)

Tools for medical diagnostics; tools for veterinary diagnostics; in-vitro diagnostic testing apparatus incorporating chemical reagents (for medical use)

Safety testing of products

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 15, 2023 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Dec 27, 2022 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 27, 2022 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 24, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 6, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 6, 2022 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Dec 27, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 27, 2021 ABN2
REFUSAL PROCESSED BY IB
Jul 5, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 14, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jun 14, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 10, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jun 9, 2021 CNRT
ASSIGNED TO EXAMINER
Jun 1, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 9, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 5, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 4, 2021 REPR